Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 26, Supplement C, 1990   [Index by Author] 


Down Other Departments
Down Articles


[Search ALL Issues]

Front Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Other Departments Back

Roger Finch, Liz Moore, David Speller, Les White, and Peter Wilkinson
Perface
J. Antimicrob. Chemother. 1990 26: iii; doi:10.1093/jac/26.suppl_C.iii [PDF] [Request Permissions]  

Articles Back

A. Bryskier, T. Procyk, and M. T. Labro
Cefodizime, a new 2-aminothiazolyl cephalosporin: physicochemical properties, toxicology and structure-activity relationships
J. Antimicrob. Chemother. 1990 26: 1-8; doi:10.1093/jac/26.suppl_C.1 [Abstract] [PDF] [Request Permissions]  

R. Wise, J. M. Andrews, and J. P. Ashby
In-vitro activity of cefodizime against respiratory pathogens
J. Antimicrob. Chemother. 1990 26: 9-12; doi:10.1093/jac/26.suppl_C.9 [Abstract] [PDF] [Request Permissions]  

C. J. Soussy, M. Chanal, and M. D. Kitzis
The in-vitro activity of cefodizime: a review
J. Antimicrob. Chemother. 1990 26: 13-21; doi:10.1093/jac/26.suppl_C.13 [Abstract] [PDF] [Request Permissions]  

J. Verhoef
Transient immunodepression
J. Antimicrob. Chemother. 1990 26: 23-29; doi:10.1093/jac/26.suppl_C.23 [Abstract] [PDF] [Request Permissions]  

R. E. Ritts
Antibiotics as biological response modifiers
J. Antimicrob. Chemother. 1990 26: 31-36; doi:10.1093/jac/26.suppl_C.31 [Abstract] [PDF] [Request Permissions]  

M. T. Labro
Cefodizime as a biological response modifier: a review of its in-vivo, ex-vivo and in-vitro immunomodulatory properties
J. Antimicrob. Chemother. 1990 26: 37-47; doi:10.1093/jac/26.suppl_C.37 [Abstract] [PDF] [Request Permissions]  

M. T. Labro and J. el Benna
Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro
J. Antimicrob. Chemother. 1990 26: 49-57; doi:10.1093/jac/26.suppl_C.49 [Abstract] [PDF] [Request Permissions]  

A. Bryskier, T. Procyk, D. Tremblay, B. Lenfant, and J. B. Fourtillan
The pharmacokinetics of cefodizime following intravenous and intramuscular administration of a single dose of 1.0 g
J. Antimicrob. Chemother. 1990 26: 59-63; doi:10.1093/jac/26.suppl_C.59 [Abstract] [PDF] [Request Permissions]  

A. Bryskier, T. Procyk, D. Tremblay, B. Lenfant, and J. B. Fourtillan
Pharmacokinetics of cefodizime administered intravenously as a single-dose (1.0 and 2.0 g) to healthy adult volunteers
J. Antimicrob. Chemother. 1990 26: 65-70; doi:10.1093/jac/26.suppl_C.65 [Abstract] [PDF] [Request Permissions]  

O. G. Nilsen, F. Rennemo, R. Rennemo, and B. Lenfant
Pharmacokinetics of cefodizime in the elderly following single and repeated intravenous administration of 1 g
J. Antimicrob. Chemother. 1990 26: 71-75; doi:10.1093/jac/26.suppl_C.71 [Abstract] [PDF] [Request Permissions]  

P. Veyssier, A. Devillers, Y. Domart, J. B. Fourtillan, A. Bryskier, and T. Procyk
Pharmacokinetics of cefodizime in elderly patients with moderate or severe renal impairment
J. Antimicrob. Chemother. 1990 26: 77-81; doi:10.1093/jac/26.suppl_C.77 [Abstract] [PDF] [Request Permissions]  

A. Boccazzi, G. Fusi, A. M. Mezzopane, M. Maretti, and P. Careddu
The pharmacokinetics of cefodizime in children
J. Antimicrob. Chemother. 1990 26: 83-87; doi:10.1093/jac/26.suppl_C.83 [Abstract] [PDF] [Request Permissions]  

P. Mendes, N. Lameire, B. Rosenkranz, V. Malerczyk, and D. Damm
Pharmacokinetics of cefodizime during continuous ambulatory peritoneal dialysis
J. Antimicrob. Chemother. 1990 26: 89-93; doi:10.1093/jac/26.suppl_C.89 [Abstract] [PDF] [Request Permissions]  

Jérôme Barré
Pharmacokinetics of cefodizime: a review of the data on file
J. Antimicrob. Chemother. 1990 26: 95-101; doi:10.1093/jac/26.suppl_C.95 [Abstract] [PDF] [Request Permissions]  

J. P. Sollet
An open multicentre study of the efficacy and tolerance of cefodizime 1 g bd intravenously or intramuscularly in lower respiratory tract infections
J. Antimicrob. Chemother. 1990 26: 103-110; doi:10.1093/jac/26.suppl_C.103 [Abstract] [PDF] [Request Permissions]  

O. Kourilsky
Efficacy and tolerance of cefodizime in the treatment of acute pyelonephritis
J. Antimicrob. Chemother. 1990 26: 111-116; doi:10.1093/jac/26.suppl_C.111 [Abstract] [PDF] [Request Permissions]  

Giuliana Gialdroni Grassi
Cefodizime in clinical use: a review of the clinical trial reports
J. Antimicrob. Chemother. 1990 26: 117-125; doi:10.1093/jac/26.suppl_C.117 [Abstract] [PDF] [Request Permissions]  

M. R. Perianu
Clinical safety profile of cefodizime
J. Antimicrob. Chemother. 1990 26: 127-134; doi:10.1093/jac/26.suppl_C.127 [Abstract] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.